EP Patent

EP1957494A2 — Lactam compounds and methods of using the same

Assigned to Incyte Holdings Corp · Expires 2008-08-20 · 18y expired

What this patent protects

The present invention relates to inhibitors of 11-ß hydroxyl steroid dehydrogenase type 1 and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-ß hydroxyl steroid deh…

USPTO Abstract

The present invention relates to inhibitors of 11-ß hydroxyl steroid dehydrogenase type 1 and pharmaceutical compositions thereof. The compounds of the invention can be useful in the treatment of various diseases associated with expression or activity of 11-ß hydroxyl steroid dehydrogenase type 1.

Drugs covered by this patent

Patent Metadata

Patent number
EP1957494A2
Jurisdiction
EP
Classification
—
Expires
2008-08-20
Drug substance claim
No
Drug product claim
No
Assignee
Incyte Holdings Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.